Literature DB >> 6378157

Experimental uveitis. Elicited by peptidoglycan-polysaccharide complexes, lipopolysaccharide, and muramyl dipeptide.

A Fox, M E Hammer, P Lill, T G Burch, G Burrish.   

Abstract

Uveitis could be a reaction to bacterial debris disseminated to the eye from extraocular sites of infection. In this study, we relate the composition of several bacterial components to their inflammatory properties in the eye. Groups of rabbits were injected intravitreously with peptidoglycan-polysaccharide (PG-PS) complexes isolated from group A streptococci, Escherichia coli lipopolysaccharide (LPS), or synthetic muramyl dipeptide (MDP). The lipid A region of LPS and the glycan backbone of PG are chemical analogues; MDP is the minimal biologically active subunit of PG. All of these molecules elicited uveitis as observed both clinically and histologically. The MDP elicited an acute inflammation characterized by a heterophil and monocyte infiltrate that subsided within 16 days. The PG-PS and LPS elicited chronic inflammation characterized by mononuclear and lymphocyte infiltration and severe necrosis of the retina.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378157     DOI: 10.1001/archopht.1984.01040030857033

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  13 in total

1.  Investigation of the differential potentials of TLR agonists to elicit uveitis in mice.

Authors:  Jordan J Allensworth; Stephen R Planck; James T Rosenbaum; Holly L Rosenzweig
Journal:  J Leukoc Biol       Date:  2011-09-20       Impact factor: 4.962

2.  Severe bacterial endophthalmitis: towards improving clinical outcomes.

Authors:  Billy D Novosad; Michelle C Callegan
Journal:  Expert Rev Ophthalmol       Date:  2010-10

Review 3.  Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions.

Authors:  Michelle C Callegan; Michael Engelbert; David W Parke; Bradley D Jett; Michael S Gilmore
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

4.  Pathogenesis of gram-positive bacterial endophthalmitis.

Authors:  M C Callegan; M C Booth; B D Jett; M S Gilmore
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

Review 5.  Bacterial endophthalmitis: therapeutic challenges and host-pathogen interactions.

Authors:  Michelle C Callegan; Michael S Gilmore; Meredith Gregory; Raniyah T Ramadan; Brandt J Wiskur; Andrea L Moyer; Jonathan J Hunt; Billy D Novosad
Journal:  Prog Retin Eye Res       Date:  2007-01-22       Impact factor: 21.198

6.  NOD2, the gene responsible for familial granulomatous uveitis, in a mouse model of uveitis.

Authors:  Holly L Rosenzweig; Tammy M Martin; Monica M Jann; Stephen R Planck; Michael P Davey; Koichi Kobayashi; Richard A Flavell; James T Rosenbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

7.  Uveitis induction in the rabbit by muramyl dipeptides.

Authors:  R V Waters; T G Terrell; G H Jones
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

8.  Degradation of muramyl dipeptide by mammalian serum.

Authors:  J Harrison; A Fox
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

9.  Recurrent bilateral retinal vasculitis as a manifestation of post-streptococcal uveitis syndrome.

Authors:  Jinu Han; Sung Chul Lee; Won Kyung Song
Journal:  Korean J Ophthalmol       Date:  2012-07-24

10.  Supplemental treatment of rheumatoid arthritis with natural milk antibodies against enteromicrobes and their toxins: results of an open-labelled pilot study.

Authors:  Kou Katayama; Takeo Matsuno; Takaki Waritani; Kuniaki Terato; Hiroshi Shionoya
Journal:  Nutr J       Date:  2011-01-06       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.